Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oed

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Lancet (London, England)|February 3, 1999
Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study GroupJ S Smolen, J R Kalden, D L Scott, et al.
Scandinavian Journal of Rheumatology|July 27, 2001
Slowing of disease progression in rheumatoid arthritis patients during long-term treatment with leflunomide or sulfasalazineA Larsen, T K Kvien, M Schattenkirchner, et al.
The Journal of Rheumatology|September 12, 2001
Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study GroupJ R Kalden, D L Scott, J S Smolen, et al.
Annals of the Rheumatic Diseases|September 15, 2001
Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazineD L Scott, J S Smolen, J R Kalden, et al.
Rheumatology (Oxford, England)|July 11, 2000
A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritisP Emery, F C Breedveld, E M Lemmel, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Lancet (London, England)|February 3, 1999
Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study GroupJ S Smolen, J R Kalden, D L Scott, et al.
Scandinavian Journal of Rheumatology|July 27, 2001
Slowing of disease progression in rheumatoid arthritis patients during long-term treatment with leflunomide or sulfasalazineA Larsen, T K Kvien, M Schattenkirchner, et al.
The Journal of Rheumatology|September 12, 2001
Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study GroupJ R Kalden, D L Scott, J S Smolen, et al.
Annals of the Rheumatic Diseases|September 15, 2001
Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazineD L Scott, J S Smolen, J R Kalden, et al.
Rheumatology (Oxford, England)|July 11, 2000
A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritisP Emery, F C Breedveld, E M Lemmel, et al.
Pageof 2